Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000504233 | SCV000593377 | likely benign | not specified | 2016-07-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311814 | SCV000846760 | benign | Inborn genetic diseases | 2017-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001613319 | SCV001838962 | benign | not provided | 2019-10-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001613319 | SCV002282451 | likely benign | not provided | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001613319 | SCV004162507 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | ARID1B: BS1 |
Prevention |
RCV003972825 | SCV004791081 | likely benign | ARID1B-related condition | 2020-10-13 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |